FIELD: biotechnology; polypeptide synthesis.
SUBSTANCE: invention discloses a new approach to the liquid-phase synthesis of the WNT Foxy-5 hexapeptide, as well as to its protected derivatives and peptide fragments, making it possible to obtain higher yields of the target product.
EFFECT: new approach to synthesis.
6 cl, 16 ex, 8 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| LINEAR LIQUID PATHWAYS FOR WNT HEXAPEPTIDES | 2019 |
|
RU2799031C2 |
| PEPTIDES IN COMBINATION WITH IMMUNE CHECKPOINT INHIBITORS FOR USE IN TREATING CANCER | 2020 |
|
RU2826955C2 |
| GLYCATED PEPTIDE GLP-1 | 2009 |
|
RU2543157C2 |
| GLP-1 PEPTIDE HAVING ATTACHED OLIGOSACCHARIDE CHAIN | 2008 |
|
RU2539829C2 |
| ANALOGUES OF INSULIN-LIKE GROWTH FACTOR-1 (IGF-1), CONTAINING AMINO ACID SUBSTITUTION IN POSITION 59 | 2010 |
|
RU2511577C2 |
| NEOANTIGENS AND THEIR USE | 2019 |
|
RU2813924C2 |
| PROCESS FOR PREPARATION OF GLYCOPEPTIDE HAVING SIALYLATED SUGAR CHAIN, AND METHOD FOR PRODUCING SIALYL GLYCOASPARAGINE | 2012 |
|
RU2586524C2 |
| ANALOGUES OF EGF(A) WITH SUBSTITUENTS-FATTY ACIDS | 2017 |
|
RU2747877C2 |
| FGF21 DERIVATIVES AND USE THEREOF | 2015 |
|
RU2729011C2 |
| KV1_3 BLOCKERS | 2020 |
|
RU2825633C1 |
